Charles Schwab’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Buy |
|
|||||
|
2025
Q1 | $860K | Sell |
|
|||||
|
2024
Q4 | $1.39M | Buy |
|
|||||
|
2024
Q3 | $1.43M | Buy |
|
|||||
|
2024
Q2 | $275K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $57K | Sell |
|
|||||
|
2021
Q1 | $397K | Buy |
|
|||||
|
2020
Q4 | $324K | Hold |
|
|||||
|
2020
Q3 | $221K | Buy |
|
|||||
|
2020
Q2 | $255K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $226K | Buy |
|
|||||
|
2018
Q4 | $175K | Hold |
|
|||||
|
2018
Q3 | $239K | Sell |
|
|||||
|
2018
Q2 | $297K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $177K | Hold |
|
|||||
|
2013
Q4 | $154K | Hold |
|
|||||
|
2013
Q3 | $206K | Hold |
|
|||||
|
2013
Q2 | $162K | Buy |
|